510k Submission Process for Non-Active Device
Statement of Work (SOW)
Phase 1 – Initial Details |
|||
Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
1. | Intended use |
|
|
2. | Indications of Use Statement (Form 3881) |
|
|
3. | Device Description |
|
|
4. | Predicate Device |
|
|
5. | 510(K) Summary |
|
|
Phase 2 – Non-active Device Supporting Documentation based on Intended Use & Indications for use |
||||
Document Requirements | Scope of I3CGlobal | Scope of 510(k) Applicant | ||
2.1 | Device Drawing |
|
|
|
2.2 | Material Safety Datasheet |
|
|
|
2.3 | Manufacturing Flow chart |
|
|
|
2.4 | Proposed Labelling |
|
|
|
2.5 | Sterilization (If the device is sterile) |
|
|
|
2.6 | Shelf Life |
|
|
|
2.7 | Biocompatibility |
|
|
|
2.8 | Performance Testing_ Bench |
|
|
|
2.9 | Risk Management File (Recommended only based on the risk associated with the device not mandatory for every non-active device as per FDA) |
|
|
Phase 3 – Initial Documents and Substantial Equivalence Documents |
|||
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
3.1 | CDRH Premarket Review Submission Cover Sheet (FDA Form 3514) |
|
– |
3.2 | Class III Summary and Certification |
|
– |
3.3 | Financial Certification or Disclosure Statement |
|
– |
3.4 | Software |
|
– |
3.5 | Electromagnetic Compatibility and Electric Safety |
|
– |
3.6 | Performance Testing_ Animal |
|
– |
3.7 | Performance Testing_ Clinical |
|
– |
3.4 | Executive Summary |
|
– |
3.5 | Substantial Equivalence Discussion |
|
– |
Phase 4 – Administrative Documents |
|||
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
4.1 | 510(k) Cover Letter |
|
|
4.2 | Truthful and Accuracy Statement |
|
|
4.3 | Declarations of conformity and Summary report |
|
|
4.4 | MDFUSC (FDA Form 3601) |
|
|
Phase 5 – RTA Checklist and E-Copy |
|||
Document Requirements |
Scope of I3CGlobal |
Scope of 510(k) Applicant |
|
5.1 | RTA Checklist |
|
|
5.2 | E-Copy |
|
|